Response to 'Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein'.

Bordino, Valerio; Vicentini, Costanza; Zotti, Carla Maria

Bordino, Valerio; Vicentini, Costanza; Zotti, Carla Maria.

Bordino V; Department of Public Health and Paediatrics, University of Turin, Turin, Italy.
Vicentini C; Department of Public Health and Paediatrics, University of Turin, Turin, Italy.
Zotti CM; Department of Public Health and Paediatrics, University of Turin, Turin, Italy.

Vox Sang ; 117(9): 1128, 2022 Sep.

Article in English | MEDLINE | ID: covidwho-2019641

Subject(s)

COVID-19; Spike Glycoprotein, Coronavirus; ABO Blood-Group System/genetics; Antibodies, Viral; Antibody Formation; COVID-19/prevention & control; COVID-19 Vaccines; Humans; SARS-CoV-2/genetics; Spike Glycoprotein, Coronavirus/genetics; Vaccines, Synthetic; mRNA Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Vox Sang Year: 2022 Document Type: Article Affiliation country: Vox.13340

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google